Breast Cancer

Oncology Solutions

Breast cancer is the most frequent cancer among women, impacting 2.1 million women each year. According to the WHO, it is estimated that 627,000 women died from breast cancer in 2018 which represents 15 percent of all cancer deaths among women.1 GE Healthcare has the largest global installed base for breast imaging covering the entire breast cancer continuum. The breast cancer portfolio includes 2D and 3D Mammography, Ultrasound, Automated Breast Ultrasound, MRI, CT and PET/CT. Together the Mammography and ABUS modalities are endorsed by more than 100 clinical publications worldwide.


The Patient Journey

  • Senographe Pristina™

    Mammography system to enhance patient experience, improve workflow and provide better clinical performance*.

  • Contrast Mammography

    Illuminating breast cancer detection with contrast mammography.

  • LOGIQ™ E10 Ultrasound Series

    Next-generation, leadership ultrasound that adapts to your needs, today and into the future.

  • Discovery RT Gen 3

    A specialized radiation therapy CT, ideal for oncology centers. Meets all needs for precise radiation therapy planning

  • LOGIQ™ E10 Ultrasound Series

    Next-generation, leadership ultrasound that adapts to your needs, today and into the future.

  • Seno Iris GE Mammography Solution

    Digital breast tomosynthesis (DBT) is making it easier to spot breast cancer. But this data-intensive technology can push the limits of some viewi...

The latest in Oncology

Supporting Materials

Contact Us

1. http://www.who.int/cancer/prevention/diagnosis-screening/breast-cancer/en/

JB04373XX